Literature DB >> 6765223

Effects of enhanced conventional therapy on metabolic control in children with insulin-dependent diabetes mellitus.

D Daneman, L H Epstein, L Siminerio, S Beck, G Farkas, J Figueroa, D J Becker, A L Drash.   

Abstract

We implemented a three-phase, 32-wk program to improve both self-regulation of adherence behaviors and insulin delivery in children with diabetes. Twenty children, aged 8-12 yr (mean duration 3.6 yr), enrolled. Phase 1 (wk 1-12) used behavior modification to improve diet, exercise, urine testing, and insulin adjustment, targeting an increased percentage negative urines. Feedback training and parent checks were used to improve reliability; adherence was measured using Clinitest placebos. Phase 2 (wk 13-20) was a stabilization period. Phase 3 (wk 21-32) studied the effect of insulin dose adjustment, comparing once-versus twice-daily shots in 10 pairs of children matched for %GHb. GHb, fasting plasma glucose, and lipids were measured at baseline and at the end of each phase. Results revealed a significant and sustained increase in negative urine tests, but no change in % GHb or FBG. Reliability of and adherence to urine tests were 83% and 76%, respectively. During phase 3, no significant differences were noted between groups receiving once- or twice-daily insulin injections. Thus, behavior modification resulted in increased reliability and adherence to routines, associated with a reliable increase in negative urines. This did not, however, produce changes in other control measures. Furthermore, no differences between those receiving 1 or 2 daily shots were evident.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765223     DOI: 10.2337/diacare.5.5.472

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

Review 1.  Impact of blood glucose monitoring on diabetic control: obstacles and interventions.

Authors:  T Wysocki
Journal:  J Behav Med       Date:  1989-04

2.  Psychological treatment improves hemoglobin A1c outcomes in adolescents with type 1 diabetes mellitus.

Authors:  Matthew J Bitsko; Melanie K Bean; Sarah Bart; Rebecca H Foster; Leroy Thacker; Gary L Francis
Journal:  J Clin Psychol Med Settings       Date:  2013-09

Review 3.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.